Affordable Access

Publisher Website

A genomic deep field view of hypertension.

Authors
  • Garimella, Pranav S1
  • du Toit, Clea2
  • Le, Nhu Ngoc2
  • Padmanabhan, Sandosh3
  • 1 Division of Nephrology and Hypertension, University of California San Diego, San Diego, California, USA.
  • 2 School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • 3 School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Electronic address: [email protected].
Type
Published Article
Journal
Kidney International
Publisher
Elsevier
Publication Date
Oct 29, 2022
Identifiers
DOI: 10.1016/j.kint.2022.09.029
PMID: 36377113
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Blood pressure is regulated by a complex neurohumoral system including the renin-angiotensin-aldosterone system, natriuretic peptides, endothelial pathways, the sympathetic nervous system, and the immune system. This review charts the evolution of our understanding of the genomic basis of hypertension at increasing resolution over the last 5 decades from monogenic causes to polygenic associations, spanning ∼30 monogenic rare variants and >1500 single nucleotide variants. Unexpected early wins from blood pressure genomics include deepening of our understanding of the complex causation of hypertension; refinement of causal estimates bidirectionally between blood pressure, risk factors, and outcomes through Mendelian randomization; risk stratification using polygenic risk scores; and opportunities for precision medicine and drug repurposing. Copyright © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Report this publication

Statistics

Seen <100 times